Drug store chain operator Walgreen Company (WAG) reported in a 10-Q filing on Thursday that the failure to come to terms with pharmacy benefits provider Express Scripts (ESRX) will negatively impact its 2012 earnings.
Walgreen management said it now expects full-year 2012 prescription volume to come in at around 97% to 99% of 2011 volumes.
The company will try and offset the impact of loss through cost-cutting initiatives, business expansion, and attempts to retain Express Scripts clients. WAG said it’s aiming to shave around 50% of the negative impacts with those measures.
Back in June, Walgreen announced it was unable to come to terms on a contract extension with ESRX. The current contract will expire on Jan. 1, 2012, after which WAG will no longer be a part of Express’ pharmacy benefits network.
Walgreen shares were inactive in premarket trading Thursday.
The Bottom Line
Shares of Walgreen Company (WAG) have a 2.70% dividend yield, based on last night’s closing stock price of $33.28. The stock has technical support in the $27-$30 price area. If the shares can firm up, we see overhead resistance around the $35-$36 price levels.
Walgreen Company (WAG) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.3 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here